Stocks and Investing Stocks and Investing
Tue, January 4, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Upgraded (AXS) to Hold and Held Target at $57 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
John Walsh Maintained (AYI) at Buy with Increased Target to $237 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Chris Snyder Maintained (AYI) at Hold with Increased Target to $213 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Mishan Maintained (BAX) at Buy with Increased Target to $98 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (BAX) at Buy with Increased Target to $99 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Spector Maintained (AVY) at Hold with Increased Target to $234 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Richardson Upgraded (BP) to Buy and Held Target at $36 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Jared Shaw Maintained (BOKF) at Buy with Increased Target to $115 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (BRO) at Hold with Increased Target to $66 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Spector Maintained (BERY) at Strong Buy with Decreased Target to $84 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AIG) at Hold with Decreased Target to $58 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $193 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Initiated (Z) at Hold and Held Target at $75 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Initiated (ZG) at Hold and Held Target at $75 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (ACGL) at Buy with Increased Target to $51 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
David Anderson Maintained (APG) at Buy with Increased Target to $30 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Carter Gould Downgraded (APLT) to Hold and Decreased Target to $7 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Levine Initiated (AMPS) at Strong Buy and Held Target at $13 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (AMP) at Strong Buy with Increased Target to $385 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Brennan Hawken Maintained (AMP) at Strong Buy with Increased Target to $365 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AON) at Hold with Decreased Target to $321 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (AMZN) at Buy on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Maintained (AMZN) at Buy on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Kevin McCarthy Upgraded (APD) to Strong Buy and Held Target at $335 on, Jan 4th, 2022
[ 12:00 AM ] - WOPRAI
Alexander Blostein Downgraded (APAM) to Hold and Decreased Target to $48 on, Jan 4th, 2022
Mon, January 3, 2022
[ 12:00 AM ] - WOPRAI
Devin McDermott Maintained (APA) at Buy with Increased Target to $39 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Aaron Gal Maintained (ABBV) at Buy with Increased Target to $155 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $160 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Upgraded (BXP) to Strong Buy and Increased Target to $131 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Michael Schmitz Maintained (BPMC) at Strong Buy with Increased Target to $122 on, Jan 3rd, 2022

Michael Schmitz Maintained (BPMC) at Strong Buy with Increased Target to $122 on, Jan 3rd, 2022


Published on 2024-10-27 19:06:54 - WOPRAI, Michael Schmitz
  Print publication without navigation


Michael Schmitz of Guggenheim, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $120 to $122 on, Jan 3rd, 2022.

Michael has made no other calls on BPMC in the last 4 months.



There are 2 other peers that have a rating on BPMC. Out of the 2 peers that are also analyzing BPMC, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Friday, October 29th, 2021


This is the rating of the analyst that currently disagrees with Michael

  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $133 on, Wednesday, November 10th, 2021
Contributing Sources